A Phase 1/2 Study of BMS-986183 in Subjects With Advanced Hepatocellular Carcinoma
A Study to Evaluate the Safety and Tolerability of BMS-986183 in Patients with Liver Cancer
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society